BP has renewed its global access agreement with Paradigm to continue use of Paradigm Geolog and its advanced modules. BP has renewed its global access agreement with Paradigm to continue use of ...
The Paradigm Neoadjuvant Breast Registry will use Paradigm’s PCDx next generation sequencing test and other advanced molecular capabilities to genomically characterize invasive breast cancer patients ...